Sign in with Google. Opens in new tab
bullish
Wuxi Biologics Placement - This Time It's Different
537 Views29 Jun 2020 10:42
Wuxi Biologics (Cayman) Inc (2269 HK) is looking to raise around US$660m in a primary placement. This is in contrast to the nine other placement...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 5-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Santos Ltd (STO AU): FIRB Approval For XRG's Tilt Will Be No Pushover
- BYD (1211 HK): Authorities Halting Severe Competition Throughout Industry and Industry Chain
- ENN Energy (2688 HK): ENN Natural Gas' Application Proof Is Out. Interesting For What Is Not Present
- Vishal Mega Mart (VMM IN) Placement: PE Selling Will Lead to Large Passive Buying
- [Japan M&A] NTT Docomo Buys Out Carta Holdings (3688) Minorities - Done Deal
Top Unpaywalled Insights
More »- Overview #27 – The Big Beautiful Tragi-Comedy Continues
- HK Connect SOUTHBOUND Flows (To 13 June 2025); Volumes Up, TECH Down, HEALTHCARE Bought Big
- [IO Technicals 2025/24] Downward Momentum Lingers
- China A-Share Consumer Staples: An Analysis of the Opportunities Ahead
- Bearishness Persist in Soybeans Despite Rebound Hopes
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- HSCEI Index Rebalance - Huge Turnover as WVRs & Secondary Listings Make Their Index Debut15 Aug 2020
- Hang Seng Index Rebalance - Big Turnover, Big Impact, Some Surprises and More Changes to Come15 Aug 2020
- Wuxi Biologics - Recap/Learnings from past Placements16 Jul 2020
- Wuxi Biologics Placement - Biggest Deal Size at Launch, Well Ahead of Lock-Up Expiry20 May 2020
- Wuxi Biologics Placement: Another Pre-Lockup Placement but Past Deals Have Done Well31 Mar 2020
x